Trial reportMedicine2026
Effects of flurbiprofen axetil on postoperative renal function in patients undergoing percutaneous nephrolithotomy: A prospective, randomized, double-blind, controlled clinical study.
Trial report in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThis study aims to assess the impact of low-dose flurbiprofen axetil on the incidence of perioperative acute kidney injury (AKI) in patients undergoing percutaneous nephrolithotomy (PCNL).
methodsBetween February and July 2025, 130 patients undergoing PCNL under general anesthesia at Huadu District People's Hospital of Guangzhou were enrolled and randomly allocated to either the control group (Group C, n = 65) or the flurbiprofen group (Group FA, n = 65). Following surgery, patients in Group FA received 100 mg of flurbiprofen axetil intravenously, while Group C received 10 ml of normal saline. Serum creatinine, glomerular filtration rate (GFR), cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL) levels were measured preoperatively and at 6, 24, and 48 hours postoperatively.
resultsA total of 120 patients completed the study (Group C, n = 60; Group FA, n = 60). Baseline characteristics were comparable between the 2 groups (P > .05). Five cases of AKI were observed in Group C, compared to one in Group FA, with no statistically significant difference (P = .207). At 6 hours postoperatively, NGAL levels in Group C were significantly higher than in Group FA (216.35 ± 63.39 vs 184.84 ± 43.14, P = .002). No significant differences were found in serum creatinine, NGAL, or cystatin C levels at other time points.
conclusionPostoperative administration of 100 mg flurbiprofen axetil may reduce NGAL levels at 6 hours after PCNL, indicating a potential protective effect on renal function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.